KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Co-Diagnostics (CODX) Return on Equity (2017 - 2025)

Historic Return on Equity for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to 0.79%.

  • Co-Diagnostics' Return on Equity fell 1900.0% to 0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.79%, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of 0.54% for FY2024, which is 1800.0% down from last year.
  • As of Q3 2025, Co-Diagnostics' Return on Equity stood at 0.79%, which was down 1900.0% from 0.81% recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Return on Equity registered a high of 0.71% during Q1 2021, and its lowest value of 0.81% during Q2 2025.
  • For the 5-year period, Co-Diagnostics' Return on Equity averaged around 0.18%, with its median value being 0.35% (2023).
  • As far as peak fluctuations go, Co-Diagnostics' Return on Equity skyrocketed by 12800bps in 2021, and later crashed by -5700bps in 2023.
  • Co-Diagnostics' Return on Equity (Quarter) stood at 0.31% in 2021, then tumbled by -137bps to 0.11% in 2022, then plummeted by -234bps to 0.38% in 2023, then plummeted by -67bps to 0.64% in 2024, then fell by -25bps to 0.79% in 2025.
  • Its Return on Equity stands at 0.79% for Q3 2025, versus 0.81% for Q2 2025 and 0.7% for Q1 2025.